The import of composite diagnostic or laboratory reagents to Singapore is projected to grow steadily from $831.21 million in 2024 to $958.58 million in 2028. This represents a year-on-year growth rate of approximately 3.94% from 2024 to 2025, 3.72% from 2025 to 2026, 3.51% from 2026 to 2027, and 3.33% from 2027 to 2028. Over the next five years, the compound annual growth rate (CAGR) is estimated at 3.63%.
In 2023, the actual import value was $800 million. The increased demand for healthcare and diagnostic services, along with technological advancements, heavily influences these trends. Future trends to watch for include advancements in precision medicine, increased government healthcare spending, and the potential impacts of global supply chain disruptions on reagent availability and imports.
